Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1319
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00483223 | Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response | ||
| NCT05701488 | SIRT With Tremelimumab and Durvalumab for Resectable HCC | ||
| NCT06176261 | DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs | ||
| NCT00749320 | Arterial Spin Labeling Blood Flow MRI for Evaluation of Response to Antiangiogenic and Targeted Therapies of Renal Cell Carcinoma (RCC) | ||
| NCT00954720 | Observational Study of Iron Overload in Stem Cell Transplantation | ||
| NCT00142480 | Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer | ||
| NCT01323920 | Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors | ||
| NCT03716180 | DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC | ||
| NCT01096602 | Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission | ||
| NCT00021996 | Valdecoxib in Treating Chronic Pain in Cancer Patients | ||
| NCT03773666 | A Feasibility Study of Durvalumab +/- Oleclumab as Neoadjuvant Therapy for Muscle-invasive Bladder Cancer (BLASST-2) | ||
| NCT04354454 | Step Into Support for Endurance and Strength (SISTERS) | ||
| NCT05643027 | A Novel Intervention for Patients With Cancer | ||
| NCT00165282 | Mindfulness Meditation in Bone Marrow Transplantation | ||
| NCT01078961 | An Expanded Cohort Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma | ||
| NCT00361309 | SU011248 in Advanced Hepatocellular Carcinoma | ||
| NCT05057247 | Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC | ||
| NCT03833934 | Study of Plasma NGS for Assessment, Characterization, Evaluation of Patients With ALK Resistance | ||
| NCT01228435 | IPI-504 in NSCLC Patients With ALK Translocations | ||
| NCT06366347 | ALPINE: Maintenance Letrozole/Abemaciclib | ||
| NCT05617885 | Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer | ||
| NCT02375776 | Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health Intervention | ||
| NCT00556049 | Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma | ||
| NCT01058655 | RAD001 and AV-951 in Patients With Refractory, Metastatic Colorectal Cancer | ||
| NCT05121558 | The Effect of Yoga on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy) | ||
| NCT02653755 | The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer | ||
| NCT03137537 | Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy. | ||
| NCT02390414 | The Myelodysplasia Transplantation-Associated Outcomes (MDS-TAO) Study | ||
| NCT01550458 | Safety Study of Mibefradil When Given Four Times a Day in Healthy Volunteers | ||
| NCT01002248 | Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients | ||
| NCT01754389 | Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell Transplant | ||
| NCT06040125 | Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial | ||
| NCT00644189 | Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma | ||
| NCT06208748 | SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST | ||
| NCT07563010 | Menin-Inhibitor Targeted Maintenance in AML | ||
| NCT02340676 | A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory cGVHD | ||
| NCT01647607 | Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer | ||
| NCT00146536 | Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy | ||
| NCT00436072 | ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer | ||
| NCT01067287 | Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation | ||
| NCT00428233 | Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation | ||
| NCT00831571 | Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin | ||
| NCT07482384 | Supporting Health Including Endocrine Treatment for Long Duration | ||
| NCT03818087 | Elevate! : An Elderly Breast Cancer Cohort Study | ||
| NCT05327452 | Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study | ||
| NCT00004163 | Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer | ||
| NCT00165399 | Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment | ||
| NCT03331406 | Physical Activity In Gastrointestinal Cancer | ||
| NCT01185509 | Trastuzumab and Vinorelbine in Advanced Breast Cancer | ||
| NCT06043674 | Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation |
